Literature DB >> 2697940

Significance of sequential cellular changes inside and outside foci of altered hepatocytes during hepatocarcinogenesis.

P Bannasch1, H Enzmann, F Klimek, E Weber, H Zerban.   

Abstract

A variety of phenotypic cellular changes emerge in the liver of different species prior to the appearance of hepatocellular adenomas and carcinomas induced by carcinogenic agents (chemicals, radiation, hepadna viruses) or develop "spontaneously." Foci of altered hepatocytes have been studied most extensively in rats treated with chemical carcinogens; they are considered preneoplastic lesions and have been used in several laboratories as endpoints in carcinogenicity testing. The principles and problems of the morphological classification of foci of altered hepatocytes are presented. In addition to the 4 types of foci generally accepted (clear, acidophilic, basophilic and mixed cell foci), further subtypes (intermediate cell foci) or other types of foci, namely tigroid cell foci and amphophilic cell foci, have more recently been separated as distinct pathomorphological entities. Whereas the amphophilic foci might result from a modulation of clear and acidophilic cell foci, the tigroid cell foci apparently represent a stage in a separate cell lineage leading to hepatocellular adenomas. It remains open whether the tigroid cell foci may also progress to carcinomas. Extrafocal phenotypic changes of hepatocytes might also be involved in hepatocarcinogenesis. The cellular phenotypes within foci also depend strongly, among many other factors, on the dose and duration of the carcinogenic treatment. Cytomorphological, cytochemical, microbiochemical and stereological studies suggest that the predominant sequence of cellular changes during hepatocarcinogenesis leads from the clear and acidophilic cell foci storing glycogen in excess through mixed cell foci and nodules to basophilic cell populations prevailing in hepatocellular carcinomas. A multitude of metabolic aberrations is associated with the sequential cellular changes. Aberrations in carbohydrate metabolism are particularly prominent and might be causally related to the neoplastic transformation of the hepatocytes.

Entities:  

Mesh:

Year:  1989        PMID: 2697940     DOI: 10.1177/0192623389017004107

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  10 in total

1.  The stem cells of the liver--a selective review.

Authors:  K Aterman
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

2.  Effects of sorafenib and cisplatin on preneoplastic foci of altered hepatocytes in fetal turkey liver.

Authors:  Bettina Kaestner; Karsten Spicher; Ulrich Jaehde; Harald Enzmann
Journal:  Toxicol Res (Camb)       Date:  2016-11-02       Impact factor: 3.524

Review 3.  Hepatic neoplasia: reflections and ruminations.

Authors:  K Aterman
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

Review 4.  Early bioenergetic changes in hepatocarcinogenesis: preneoplastic phenotypes mimic responses to insulin and thyroid hormone.

Authors:  P Bannasch; F Klimek; D Mayer
Journal:  J Bioenerg Biomembr       Date:  1997-08       Impact factor: 2.945

5.  Phenotypic patterns of preneoplastic and neoplastic hepatic lesions in woodchucks infected with woodchuck hepatitis virus.

Authors:  I Toshkov; H J Hacker; M Roggendorf; P Bannasch
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

6.  Targeting MEK is effective chemoprevention of hepatocellular carcinoma in TGF-alpha-transgenic mice.

Authors:  Sabrina C Wentz; Huangbing Wu; Michele T Yip-Schneider; Matthew Hennig; Patrick J Klein; Judith Sebolt-Leopold; C Max Schmidt
Journal:  J Gastrointest Surg       Date:  2007-11-07       Impact factor: 3.452

7.  Comparative toxicity of four chlorinated dibenzo-p-dioxins (CDDs) and their mixture. Part II: Structure-activity relationships with inhibition of hepatic phosphoenolpyruvate carboxykinase, pyruvate carboxylase, and gamma-glutamyl transpeptidase activities.

Authors:  L W Weber; M Lebofsky; B U Stahl; A Kettrup; K Rozman
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

8.  Comparative histomorphological review of rat and human hepatocellular proliferative lesions.

Authors:  Bob Thoolen; Fiebo J W Ten Kate; Paul J van Diest; David E Malarkey; Susan A Elmore; Robert R Maronpot
Journal:  J Toxicol Pathol       Date:  2012-10-01       Impact factor: 1.628

Review 9.  Mouse models of liver cancer: Progress and recommendations.

Authors:  Li He; De-An Tian; Pei-Yuan Li; Xing-Xing He
Journal:  Oncotarget       Date:  2015-09-15

10.  Cytokeratin-19 positivity is acquired along cancer progression and does not predict cell origin in rat hepatocarcinogenesis.

Authors:  Marta Anna Kowalik; Pia Sulas; Giovanna Maria Ledda-Columbano; Silvia Giordano; Amedeo Columbano; Andrea Perra
Journal:  Oncotarget       Date:  2015-11-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.